These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35964449)

  • 1. Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States.
    Levin A; Nagib PB; Deiparine S; Gao T; Mitchell J; Davis AK
    Int J Drug Policy; 2022 Oct; 108():103816. PubMed ID: 35964449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Medical Students' Perceptions of Psilocybin-Assisted Therapy for Use in Medical Practice.
    Wang K; Sun Y; Nava B; Sampiere L; Jacobs RJ
    Cureus; 2023 Apr; 15(4):e37450. PubMed ID: 37181969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin.
    Varker T; Watson L; Gibson K; Forbes D; O'Donnell ML
    J Psychoactive Drugs; 2021; 53(1):85-95. PubMed ID: 32931403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine.
    Marks KR; Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR
    J Clin Psychopharmacol; 2016 Jun; 36(3):213-21. PubMed ID: 27043121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological and subjective effects of acute intranasal methamphetamine during extended-release alprazolam maintenance.
    Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR
    Drug Alcohol Depend; 2011 Dec; 119(3):187-93. PubMed ID: 21737214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatrists' knowledge and attitudes about costs of commonly prescribed treatments in psychiatry.
    Bellian DP; King KA; Wahl J; Price JH
    J Community Health; 2001 Feb; 26(1):11-22. PubMed ID: 11297187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current situation and clinical characteristics of sedative-related disorder patients in Japan: a comparison with methamphetamine-related disorder patients].
    Matsumoto T; Ozaki S; Kobayashi O; Wada K
    Seishin Shinkeigaku Zasshi; 2011; 113(12):1184-98. PubMed ID: 22352004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Weighing the benefits and harms of psychotropic and analgesic substances - A perspective of German addiction medicine experts].
    Bonnet U; Specka M; Soyka M; Alberti T; Bender S; Hilger J; Hillemacher T; Kuhlmann T; Kuhn J; Lüdecke C; Reimer J; Schneider U; Schroeder W; Stuppe M; Wiesbeck G; Wodarz N; Scherbaum N
    Fortschr Neurol Psychiatr; 2022 Jan; 90(1-02):19-29. PubMed ID: 33634461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency department visits due to new psychoactive substances and other illicit drugs in Taiwan: preliminary results of the Taiwan Emergency Department Drug Abuse Surveillance (TEDAS) project.
    Lin CC; Weng TI; Ng CJ; Shih CP; Hsu J; Liao YC; Yang CC; Fang CC;
    Clin Toxicol (Phila); 2022 Jun; 60(6):708-715. PubMed ID: 35315299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].
    Jalenques I; Ortega V; Legrand G; Auclair C
    Encephale; 2016 Apr; 42(2):124-9. PubMed ID: 26796558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in long-term relapse rates between youths with ketamine use and those with stimulants use.
    Wang LJ; Chen MY; Lin CY; Chong MY; Chou WJ; You YH; Tsai CP; Chen YS; Lu SF
    Subst Abuse Treat Prev Policy; 2018 Dec; 13(1):50. PubMed ID: 30577882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample.
    Winstock AR; Kaar S; Borschmann R
    J Psychopharmacol; 2014 Jan; 28(1):49-54. PubMed ID: 24284475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project.
    Helander A; Beck O; Hägerkvist R; Hultén P
    Scand J Clin Lab Invest; 2013 Aug; 73(5):400-6. PubMed ID: 23692208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of illegal drug use pattern in Taiwan and Korea from 2006 to 2014.
    Feng LY; Yu WJ; Chang WT; Han E; Chung H; Li JH
    Subst Abuse Treat Prev Policy; 2016 Sep; 11(1):34. PubMed ID: 27663984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-national study of drug treatment decisions in psychiatry.
    Fisch HU; Gillis JS; Daguet R
    Med Decis Making; 1982; 2(2):167-7. PubMed ID: 7167045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.
    Wu LT; Schlenger WE; Galvin DM
    Drug Alcohol Depend; 2006 Sep; 84(1):102-13. PubMed ID: 16483730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypharmacy in psychiatry: a multi-state comparison of psychotropic drug combinations.
    Sheppard C; Beyel V; Fracchia J; Merlis S
    Dis Nerv Syst; 1974 Apr; 35(4):183-9. PubMed ID: 17894114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New psychoactive substances abuse among patients with access to methadone maintenance treatment in Jiangsu province: a case-control study].
    Cheng Z; Chen GH; Dai MM; Luo W; Lyu P; Cao XB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):625-630. PubMed ID: 29860806
    [No Abstract]   [Full Text] [Related]  

  • 19. Substance abuse effects on urinary tract: methamphetamine and ketamine.
    Yee CH; Ng CF; Hong YL; Lai PT; Tam YH
    Hong Kong Med J; 2019 Dec; 25(6):438-443. PubMed ID: 31796640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-medical use of psychoactive prescription drugs is associated with fatal poisoning.
    Haukka J; Kriikku P; Mariottini C; Partonen T; Ojanperä I
    Addiction; 2018 Mar; 113(3):464-472. PubMed ID: 28841781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.